Nanoparticles-based biosensor devices developed for point-of-care (POC) analyses of c-reactive protein (CRP) as the clinically important inflammatory biomarker DOI
Pari Karami,

Taha Afsar,

Danial Gholamin

et al.

Chemical Papers, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 18, 2024

Language: Английский

Trends in Aptasensing and the Enhancement of Diagnostic Efficiency and Accuracy DOI
Mohammad A. Ansari, Damini Verma,

Mohd-Akmal Hamizan

et al.

ACS Synthetic Biology, Journal Year: 2025, Volume and Issue: 14(1), P. 21 - 40

Published: Jan. 6, 2025

The field of healthcare diagnostics is navigating complex challenges driven by evolving patient demographics and the rapid advancement new technologies worldwide. In response to these challenges, biosensors offer distinctive advantages over traditional diagnostic methods, such as cost-effectiveness, enhanced specificity, adaptability, making their integration with point-of-care (POC) platforms more feasible. recent years, aptasensors have significantly evolved in capabilities through emerging microfluidics, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems, wearable devices, machine learning (ML), driving progress precision medicine global solutions. Moreover, advancements not only improve accuracy but also hold potential revolutionize early detection, reduce costs, outcomes, especially resource-limited settings. This Account examines key advancements, focusing on how scientific breakthroughs, including artificial intelligence (AI), improved sensitivity precision. Additionally, has enabled real-time monitoring data analysis, fostering advances personalized healthcare. Furthermore, commercialization aptasensor could increase availability clinical settings support use widespread solutions for health challenges. Hence, this review discusses technological improvements, practical uses, prospects while surrounding standardization, validation, interdisciplinary collaboration application. Finally, ongoing efforts address are ensure that can be effectively implemented diverse systems.

Language: Английский

Citations

2

Recent Progress in Flexible Microelectrode Arrays for Combined Electrophysiological and Electrochemical Sensing DOI Creative Commons

Umisha Siwakoti,

Steven A. Jones, Deepak Kumbhare

et al.

Biosensors, Journal Year: 2025, Volume and Issue: 15(2), P. 100 - 100

Published: Feb. 10, 2025

Understanding brain function requires advanced neural probes to monitor electrical and chemical signaling across multiple timescales regions. Microelectrode arrays (MEAs) are widely used record neurophysiological activity various depths regions, providing single-unit resolution for extended periods. Recent advancements in flexible MEAs, built on micrometer-thick polymer substrates, have improved integration with tissue by mimicking the brain's soft nature, reducing mechanical trauma inflammation. These flexible, subcellular-scale MEAs can stable signals months, making them ideal long-term studies. In addition recording, been functionalized electrochemical neurotransmitter detection. Electroactive neurotransmitters, such as dopamine, serotonin, adenosine, be directly measured via methods, particularly carbon-based surfaces. For non-electroactive neurotransmitters like acetylcholine, glutamate, γ-aminobutyric acid, alternative strategies, enzyme immobilization aptamer-based recognition, employed generate signals. This review highlights recent developments MEA fabrication functionalization achieve both electrophysiological recordings, minimizing sensor fowling damage when implanted long-term. It covers multi-time scale detection, development of conducting nanomaterial composite coatings enhance sensitivity, incorporation recognition carbon electrodes MEAs. Finally, it summarizes strategies acquire measurements from same device.

Language: Английский

Citations

1

Electrochemical biosensors for depression: Diagnosis and therapeutic monitoring DOI
Amir Asadi,

Felora Ferdosi,

Sanam Anoosheh

et al.

Clinica Chimica Acta, Journal Year: 2024, Volume and Issue: 567, P. 120091 - 120091

Published: Dec. 15, 2024

Language: Английский

Citations

3

A comprehensive review of neurotransmitter modulation via artificial intelligence: A new frontier in personalized neurobiochemistry DOI

Jaleh Bagheri Hamzyan Olia,

Arasu Raman, Chou‐Yi Hsu

et al.

Computers in Biology and Medicine, Journal Year: 2025, Volume and Issue: 189, P. 109984 - 109984

Published: March 14, 2025

Language: Английский

Citations

0

A wearable electrochemical aptasensor based MOF on MOF heterostructure for multi-neurotransmitters monitoring DOI Creative Commons
Zina Fredj, Fahimeh Marvi, Fateh Ullah

et al.

Microchimica Acta, Journal Year: 2025, Volume and Issue: 192(6)

Published: May 28, 2025

Language: Английский

Citations

0

Electrochemical biosensors for dopamine DOI
Hang Zhu,

Guifen Xu

Clinica Chimica Acta, Journal Year: 2024, Volume and Issue: 566, P. 120039 - 120039

Published: Nov. 15, 2024

Language: Английский

Citations

1

Nanoparticles-based biosensor devices developed for point-of-care (POC) analyses of c-reactive protein (CRP) as the clinically important inflammatory biomarker DOI
Pari Karami,

Taha Afsar,

Danial Gholamin

et al.

Chemical Papers, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 18, 2024

Language: Английский

Citations

1